Latest Articles
-
Meet Our Editorial Board Member
Volume 18 Issue 4
Author(s): M. Haber
Pages: 305-305 (1)
Free -
Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer
Volume 18 Issue 4
Author(s): Heena Singla, Anjana Munshi*, Raja Paramjit Singh Banipal and Vinod Kumar*
Pages: 306-327 (22)
-
Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
Volume 18 Issue 4
Author(s): Shirin Eyvazi, Bahram Kazemi, Siavoush Dastmalchi* and Mojgan Bandehpour*
Pages: 328-336 (9)
-
Synthetic Lethality: From Research to Precision Cancer Nanomedicine
Volume 18 Issue 4
Author(s): Anuradha Gupta, Anas Ahmad, Aqib Iqbal Dar and Rehan Khan*
Pages: 337-346 (10)
-
Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy
Volume 18 Issue 4
Author(s): Xinyi Wang, Haiyang Zhang, Haiou Yang, Ming Bai, Tao Ning, Shuang Li, Jialu Li, Ting Deng, Guoguang Ying* and Yi Ba*
Pages: 347-354 (8)
-
The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
Volume 18 Issue 4
Author(s): Dearbhaile C. Collins, Maxime Chenard-Poirier and Juanita S. Lopez*
Pages: 355-364 (10)
-
Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia
Volume 18 Issue 4
Author(s): Denis V. Mishchenko, Margarita E. Neganova, Elena N. Klimanova, Tatyana E. Sashenkova, Sergey G. Klochkov, Elena F. Shevtsova, Igor V. Vystorop, Vadim V. Tarasov, Vladimir N. Chubarev, Anna N. Samsonova, Ghulam Md Ashraf, George Barreto, Nagendra Sastry Yarla and Gjumrakch Aliev*
Pages: 365-371 (7)
-
DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma
Volume 18 Issue 4
Author(s): Magda F. Mohamed, Amr Mohamed Abdelmoniem, Ahmed H.M. Elwahy* and Ismail A. Abdelhamid*
Pages: 372-381 (10)
-
FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer
Volume 18 Issue 4
Author(s): Jiali Wu, Peng Liu, Hailin Tang, Zeyu Shuang, Qingsheng Qiu, Lijuan Zhang, Cailu Song, Lingrui Liu, Xiaoming Xie* and Xiangsheng Xiao*
Pages: 382-389 (8)
-
Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer
Volume 18 Issue 4
Author(s): Hailin Tang, Fu Peng, Xiaojia Huang, Xinhua Xie, Bo Chen, Jiangang Shen, Fei Gao, Jieshu You, Xiaoming Xie* and Jianping Chen*
Pages: 390-399 (10)
Endorsement(s)
"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets"
Paul Workman
CRC Centre for Cancer Therapeutics, England
Announcements
About Publisher
Bentham Science: An Introduction
We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBooks.
Subscription Information:
All Journals are available online. For information on the Journals and how to order, please visit our web site at: www.benthamscience.com/journal/price-order.php and select "Prices and Ordering" or contact our subscription department at: subscriptions@benthamscience.org
Open Access:
Bentham Science currently offers authors the choice of publishing their articles as open access. Please refer to the Journal instructions for authors for details.
Indexed in
